Month: January 2022

No Picture
Los Angeles Biotech News

Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand, Reports: 4Q21 and 2021 Net Income per Share – Diluted of $0.47 and $3.82, respectively; 4Q21 and 2021 FFO per Share – Diluted, As Adjusted, of $1.97 and $7.76, respectively

January 31, 2022 Los Angeles Biotechnology Network News Comments Off on Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand, Reports: 4Q21 and 2021 Net Income per Share – Diluted of $0.47 and $3.82, respectively; 4Q21 and 2021 FFO per Share – Diluted, As Adjusted, of $1.97 and $7.76, respectively

PASADENA, Calif.: PASADENA, Calif., Jan. 31, 2022 /PRNewswire/ — Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the fourth quarter and year ended December 31, 2021. Key highlights Operating results 4Q21 … […]

No Picture
Los Angeles Biotech News

Cryo-EM focused biotech from longtime NIH veteran secures $40M backing from Bayer in Series A

January 31, 2022 Los Angeles Biotechnology Network News Comments Off on Cryo-EM focused biotech from longtime NIH veteran secures $40M backing from Bayer in Series A

“It’s always nice to get money in the bank.” That’s what Gandeeva Therapeutics’ founder and CEO Sriram Subramaniam said, after revealing that his company landed $40 million in Series A funding. Gandeeva will use the money for its artificial intelligenc… […]

No Picture
Los Angeles Biotech News

ChromaDex External Research Program (CERP™) Celebrates 100 Peer-Reviewed Published Studies on Niagen® and Other Ingredients

January 31, 2022 Los Angeles Biotechnology Network News Comments Off on ChromaDex External Research Program (CERP™) Celebrates 100 Peer-Reviewed Published Studies on Niagen® and Other Ingredients

LOS ANGELES–(BUSINESS WIRE)—- $CDXC #niagen–ChromaDex Corp. (NASDAQ:CDXC) celebrates the ChromaDex External Research Program’s (CERP™) 100th published peer-reviewed study on the company’s flagship ingredient Niagen® (patented nicotinamide riboside,… […]

No Picture
Los Angeles Biotech News

Virgin Orbit Adds Distinguished Spaceflight Engineering Executive Amidst Operations Scale Up

January 28, 2022 Los Angeles Biotechnology Network News Comments Off on Virgin Orbit Adds Distinguished Spaceflight Engineering Executive Amidst Operations Scale Up

LONG BEACH, Calif.–(BUSINESS WIRE)–Leading US-based space launch and space services company Virgin Orbit (Nasdaq: VORB) announced today the addition of industry leader Dr. Candace Givens as its new Vice President of Engineering. Dr. Givens joins the … […]

No Picture
Los Angeles Biotech News

Novoron Bioscience Awarded NIH Grant for Research Into Alzheimer’s Disease

January 28, 2022 Los Angeles Biotechnology Network News Comments Off on Novoron Bioscience Awarded NIH Grant for Research Into Alzheimer’s Disease

SAN DIEGO: SAN DIEGO, Jan. 28, 2022 /PRNewswire/ — Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, announced today that they have been awarded an NIA/NIH g… […]

No Picture
Los Angeles Biotech News

EmeritusDX Announces Launch of UTIDX™ to Advance Patient Care in Urology

January 28, 2022 Los Angeles Biotechnology Network News Comments Off on EmeritusDX Announces Launch of UTIDX™ to Advance Patient Care in Urology

IRVINE, Calif.: IRVINE, Calif., Jan. 27, 2022 /PRNewswire-PRWeb/ — EmeritusDX, a rapidly growing cancer diagnostics and information company, today announced the launch of UTIDX™, a PCR based test used for the diagnosis and treatment of Urinary Tract I… […]

No Picture
Los Angeles Biotech News

Amgen, Regeneron and others seek more detail from FDA on real-world data plans

January 27, 2022 Los Angeles Biotechnology Network News Comments Off on Amgen, Regeneron and others seek more detail from FDA on real-world data plans

Back in late September, the FDA released a long-awaited guidance on how the industry might use electronic health records (EHRs) or medical claims data in clinical studies to support a regulatory decision for effectiveness or safety. FDA+ guid­ance… […]

No Picture
Los Angeles Biotech News

Fujifilm expands in US after $100M deal for Atara’s manufacturing site and employees

January 27, 2022 Los Angeles Biotechnology Network News Comments Off on Fujifilm expands in US after $100M deal for Atara’s manufacturing site and employees

Atara Biotherapeutics has worked on advancing its allogenic T-cell therapy platform for patients with cancer and autoimmune disease for years, with much of the focus on the ever-tricky task of manufacturing such a therapy. On Wednesday, the company ann… […]